![Mohammed Malik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammed Malik
Président chez
MQ: Transforming Mental Health
Fortune : - $ au 31/05/2026
Profil
Mohammed Shahzad Ahmed Malik is currently the Chairman of Trustees Board at MQ: Transforming Mental Health and the Chairman at Orphalan SA. He is also an Independent Director at Nalu Medical, Inc., a Director at Iterum Therapeutics International Ltd., a General Partner at Advent Venture Partners LLP, and a General Partner at Advent Life Sciences LLP.
In the past, Dr. Malik served as an Independent Director at Agenus, Inc., a Director at CardioKine, Inc., an Independent Director at Conatus Pharmaceuticals, Inc., an Independent Director at Acutus Medical, Inc., a Director at NeoGuide Systems, Inc., a Director at Emergent BioSolutions, Inc., a Director at Predicant Biosciences, Inc., a Director at Pathwork Diagnostics, Inc., a Non-Executive Director at Axonics Women's Health Ltd., a Director at Algeta ASA, a Director at RespiVert Ltd., an Independent Director at Versartis, Inc., an Independent Director at Axonics, Inc., an Independent Director at Iterum Therapeutics Plc, an Independent Director at Aravive, Inc., and a Management Consultant at McKinsey & Co., Inc.
Dr. Malik obtained a graduate degree from the University of Oxford in 1988 and a doctorate degree from the University of Cambridge in 1990.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACUTUS MEDICAL, INC. 0,01% | 09/07/2025 | 3 281 ( 0,01% ) | - $ | 31/05/2026 |
Postes actifs de Mohammed Malik
| Sociétés | Poste | Début |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/04/1999 |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Corporate Officer/Principal | 01/04/1999 |
MQ: Transforming Mental Health
 MQ: Transforming Mental Health Miscellaneous Commercial ServicesCommercial Services Operates as a mental health research charity firm | Président | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Directeur/Membre du Conseil | - |
Nalu Medical, Inc.
 Nalu Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to manage intractable chronic pain | Directeur/Membre du Conseil | 01/06/2015 |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology Develops and commercializes orphan drugs | Président | - |
Anciens postes connus de Mohammed Malik
| Sociétés | Poste | Fin |
|---|---|---|
| ACUTUS MEDICAL, INC. | Directeur/Membre du Conseil | 10/08/2021 |
| ITERUM THERAPEUTICS PLC | Directeur/Membre du Conseil | 08/06/2021 |
| ARAVIVE, INC. | Directeur/Membre du Conseil | 09/01/2020 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Mohammed Malik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of human therapeutics to treat liver diseases | Health Technology |
Acutus Medical, Inc.
 Acutus Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices and electrophysiology equipment | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoGuide Systems, Inc.
 NeoGuide Systems, Inc. Medical SpecialtiesHealth Technology Develops minimally invasive surgical devices | Health Technology |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Predicant Biosciences, Inc.
 Predicant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostic tests for cancer | Health Technology |
Axonics Women's Health Ltd.
 Axonics Women's Health Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services Operates as a small molecule drug discovery company | Distribution Services |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Health Technology |
Axonics, Inc.
 Axonics, Inc. Medical SpecialtiesHealth Technology Engages in design, development and commercialization of neuromodulation solutions | Health Technology |
Nalu Medical, Inc.
Nalu Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to manage intractable chronic pain | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
MQ: Transforming Mental Health
MQ: Transforming Mental Health Miscellaneous Commercial ServicesCommercial Services Operates as a mental health research charity firm | Commercial Services |
Orphalan SA
Orphalan SA Pharmaceuticals: MajorHealth Technology Develops and commercializes orphan drugs | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Aravive, Inc.
 Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
